Harvey Robert Klingensmith
CIK: 0001800107
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Core Laboratories Inc. /DE/
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 1, 2026CLB
Core Laboratories Inc. /DE/
Exercise(M)Direct8.1K shares- - Apr 1, 2026CLB
Core Laboratories Inc. /DE/
Award(A)DirectRestricted Shares
7.9K shares- - Apr 1, 2025CLB
Core Laboratories Inc. /DE/
Exercise(M)Direct9.3K shares- - Apr 1, 2025CLB
Core Laboratories Inc. /DE/
Award(A)DirectRestricted Shares
8.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | CLB Core Laboratories Inc. /DE/ | Exercise(M) | 8,069 | - | $0 | Direct |
| Apr 1, 2026 | CLB Core Laboratories Inc. /DE/ | Award(A) Restricted Shares | 7,895 | - | - | Direct |
| Apr 1, 2025 | CLB Core Laboratories Inc. /DE/ | Exercise(M) | 9,317 | - | - | Direct |
| Apr 1, 2025 | CLB Core Laboratories Inc. /DE/ | Award(A) Restricted Shares | 8,069 | - | - | Direct |
1-4 of 4 transactions
About Klingensmith Harvey Robert
Klingensmith Harvey Robert (SEC CIK 0001800107) files insider reports with the SEC as Director of Core Laboratories Inc. /DE/ (CLB).
Signal8 holds 2 ownership filings by Klingensmith Harvey Robert, all Form 4s, filed between Apr 2, 2025 and Apr 7, 2026. Those filings report 4 transactions, from Apr 1, 2025 to Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Klingensmith Harvey Robert's filings is in HOUSTON, TX.
Recent filings by Klingensmith Harvey Robert
Other insiders filing for Core Laboratories Inc. /DE/ (CLB)
- Tattoli Mark Damian, SVP, Gen Counsel & Secretary
- Teo Sow Hang, CAO & Treasurer
- Bruno Lawrence, Chairman and CEO
- Murray Katherine, Director
- ANASTASIO CURT, Director
- Temeng Kwaku, Director